Chugai Pharmaceutical Co., Ltd. CHGCF
OTC PK
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | 9.40% | 6.94% | 9.26% | |
| Total Other Revenue | -- | 5.27% | 7.99% | 16.28% | |
| Total Revenue | -- | 8.79% | 7.09% | 10.22% | |
| Cost of Revenue | -- | 8.63% | 10.60% | 6.75% | |
| Gross Profit | -- | 8.86% | 5.61% | 11.74% | |
| SG&A Expenses | -- | 7.02% | 3.90% | 3.06% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -286.85% | 34.30% | 14.58% | |
| Total Operating Expenses | -- | 6.15% | 10.39% | 6.51% | |
| Operating Income | -- | 11.85% | 3.40% | 14.79% | |
| Income Before Tax | -- | 11.45% | 3.41% | 14.01% | |
| Income Tax Expenses | -- | 6.64% | 3.03% | 20.56% | |
| Earnings from Continuing Operations | -- | 13.39% | 3.56% | 11.54% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | 13.39% | 3.56% | 11.54% | |
| EBIT | -- | 11.85% | 3.40% | 14.79% | |
| EBITDA | -- | 11.30% | 7.32% | 18.92% | |
| EPS Basic | -- | 13.39% | 3.54% | 11.52% | |
| Normalized Basic EPS | -- | -18.71% | -30.09% | -46.01% | |
| EPS Diluted | -- | 13.39% | 3.55% | 11.52% | |
| Normalized Diluted EPS | -- | -18.70% | -30.08% | -46.01% | |
| Average Basic Shares Outstanding | -- | 0.00% | 0.03% | 0.02% | |
| Average Diluted Shares Outstanding | -- | -0.01% | 0.02% | 0.02% | |
| Dividend Per Share | -- | 27.73% | -10.56% | -10.56% | |
| Payout Ratio | -- | 0.98% | 1.17% | 0.07% | |